Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
Saved in:
| Title: | Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. |
|---|---|
| Authors: | Mai EK; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Huhn S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Miah K; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Poos AM; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Scheid C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Weisel KC; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bertsch U; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Munder M; Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany., Berlanga O; The Binding Site Group Ltd, Birmingham, United Kingdom., Hose D; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium., Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium., Jauch A; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany., Blau IW; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany., Salwender HJ; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany., Benner A; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Raab MS; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Goldschmidt H; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany., Weinhold N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany. niels.weinhold@med.uni-heidelberg.de. |
| Source: | Blood cancer journal [Blood Cancer J] 2023 Jan 04; Vol. 13 (1), pp. 1. Date of Electronic Publication: 2023 Jan 04. |
| Publication Type: | Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
